Global Veterinary Molecular Diagnostics Industry is expected to grow at a 6.84% annual pace and become a significant US$377.22 Million by 2033 | FMI

Global Veterinary Molecular Diagnostics Industry
Global Veterinary Molecular Diagnostics Industry

According to a recent market analysis by Future Market Insights (FMI), the Global Veterinary Molecular Diagnostics Industry is on track for significant growth. The market is projected to surge from US$182.1 million in 2022 to a remarkable US$377.22 million by 2033, reflecting a compelling Compound Annual Growth Rate (CAGR) of 6.84%.

The rising demand for veterinary molecular diagnostics is a key driver behind this growth, with the adoption of multiple testing panels and the increasing consolidation within the veterinary diagnostics industry playing pivotal roles. The market is expected to witness an overall demand surge, culminating in a projected total value of approximately US$352.8 million by 2032.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-6742

The market is segmented based on product, disease, species, end-user, and region. Based on product type, the market has been segmented into four segments: PCR kits, INAAT kits, microarray kits, and DNA sequencing kits.

The PCR kits segment is expected to be the fastest-growing segment over the forecast period, registering a significant CAGR of 7.8% in terms of revenue, over the forecast period. The increasing demand for advanced veterinary molecular diagnostic kits, such as RT-PCR kits, DNA sequencing kits, and microarray-based diagnostic kits owing to the growing number of diagnostic procedures in livestock and companion animals worldwide is expected to boost the growth over the forecast period.

The PCR kits segment dominates the market with a market value of US$ 63.4 Mn in 2017. Also, the segment is expected to maintain its dominance over the forecast period with a market value of US$ 124.0Mn by 2026 end and expand at a significant CAGR.

Based on disease type, the market has been segmented into Anaplasma spp., Ehrlichia spp., New Castle Disease, Influenza, Porcine Reproductive & Respiratory Syndrome (PRRS), and others.

Based on species type, the market has been segmented into livestock animals including Aquatic, Bovine, Porcine, Ovine, Poultry, and Equine.

Reach Out to Our Analyst For Your Queries
https://www.futuremarketinsights.com/ask-question/rep-gb-6742

Based on end-users, the market has been segmented into veterinary hospitals, clinical laboratories, and veterinary research institutes.

Based on region, the market has been segmented into North America, Latin America, Europe, the Asia Pacific Excluding China (APEC), China, and the Middle East and Africa (MEA).

The increasing set up of new production facilities by the key manufacturers in growing economies coupled with increasing adoption of molecular diagnostic techniques in animals is anticipated to boost the production of molecular diagnostic kits and drive the growth of the Global Veterinary Molecular Diagnostics Industry over a forecast period.

This report assesses trends driving the growth of segmental markets and offers analysis and insights into regional North America is estimated to dominate the Global Veterinary Molecular Diagnostics Industry with a maximum value share by the end of 2017. By 2026, North American and European markets cumulatively are expected to account for over 67.8% revenue share of the global Global Veterinary Molecular Diagnostics Industry by the end of 2026.

Some key companies covered in this report include bioMérieux SA, IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Neogen Corporation, ID.Vet, INDICAL BIOSCIENCE GmbH, and Veterinary Molecular Diagnostics, Inc. These leading players focus on consolidating their position in the Global Veterinary Molecular Diagnostics Industry by actively participating in activities such as partnerships, mergers, acquisitions, and collaborations. Companies focus on extending their product line and expanding production capacities to meet the growing demands for veterinary molecular diagnostics kits worldwide.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-6742

The Global Veterinary Molecular Diagnostics Industry is segmented as follows:

By Product Type

  • PCR kits
  • INAAT kits
  • Microarray kits
  • DNA sequencing kits

By Disease Type

  • Anaplasma spp.
  • Ehrlichia spp.
  • New Castle Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)
  • Others

By Species

  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Ovine
    • Poultry
    • Equine
  • Companion Animals
    • Canine
    • Feline
    • Avian

By End User

  • Veterinary Hospitals
  • Clinical Laboratories
  • Veterinary Research Institutes

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *